In the treatment of leukemia, not all patients respond equally to standard therapies. Drug resistance and genetic mutations can significantly reduce the effectiveness of commonly

Multiple myeloma is a chronic and often relapsing hematologic malignancy that requires long-term, repeated treatment. Over the past decade, therapeutic advances—particularly the introduction of monoclonal

Biologic therapies have fundamentally changed how chronic inflammatory diseases are treated, shifting the focus from broad immunosuppression to targeted immune modulation. From this evolving therapeutic

What is Taltz ixekizumab used for? This is a common question among patients and healthcare professionals seeking clearer information about modern biologic therapies for immune-mediated

In global oncology practice, cancer anorexia–cachexia syndrome (CACS) is a common and clinically significant complication, characterized by appetite loss, involuntary weight loss, and skeletal muscle

Lung cancer has long been one of the leading causes of cancer incidence and mortality worldwide. With rapid advances in molecular biology, immunology, and drug

Prostate cancer remains one of the most commonly diagnosed malignancies among men worldwide, and despite significant advances in diagnosis and treatment, disease progression and therapeutic